Details Basic Details Approval Date Friday, August 10, 2018 Health Outcome(s) arterial thrombotic events, venous thromboembolism (VTE) Regulatory Link(s) (2) ARIA Memo FDA Approval Package Link(s) Sentinel Drug Study: Annovera (Segesterone Acetate and Ethinyl Estradiol Vaginal System) & Arterial Thromboembolism (ATE) and Venous Thromboembolism (VTE)